- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03574272
Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology
Demonstration and Multi-center Verification of the Patient Transfer Monitoring System in Hospital Using Mobile IoT Technology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hospitalized patients who need transfer for a diagnostic examination or rehabilitation therapy during hospitalization, and have a risk of hypoxemia during transfer will be enrolled in this trial. The subjects will be provided with a portable oximeter and a smart-phone which application for monitoring is installed, and oxygen saturation and pulse rate will be checked in real time during transfer. The collected data will be transferred to cloud system via Iot network, and the transmitted data will be monitored in real time via monitoring equipment in the (Patient-hospitalized) ward. If there is a risk, the alarm system is activated so that the medical team is able to check risk factor and manage it immediately.
All the risk factors and severity will be collected during transfer, also these are checked whether the monitoring system and the data transmission system work properly or not, the time from detecting risk factor to medical response, the composition of medical staffs who responding to alarmed risk factors and improvement of the subjects.
Pilot study will be conducted with 20 subjects in Asan medical center. In pilot study, monitoring machines (HR, SpO2 monitor) commonly used in wards or hospitals will be used to verify the stability of oximeter used in this study and the developed risk detection system.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Daejeon, Korea, Republic of, 35262
- DAVINCI hospital
-
Seoul, Korea, Republic of, 05505
- Asan Medical Center
-
Seoul, Korea, Republic of, 02447
- Kyunghee University Medical Center
-
Wonju, Korea, Republic of, 26426
- Wonju Severance Christian Hospital
-
-
Gangwon-Do
-
Chuncheon, Gangwon-Do, Korea, Republic of, 24289
- Kangwon National Univeristy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A hospitalized patients in pulmonology department or rehabilitation hospital who have a risk of decreasing oxygen saturation
- A patients who require transfer in the hospital for a diagnostic examination or rehabilitation therapy during hospitalization
- Patients who need oxygen saturation monitoring according to the investigator's judgment
- Patients who voluntarily agree to study participation and provide written informed consent form
Exclusion Criteria:
- Patients who don't agree with the study procedure or are uncooperative
- Repeated monitoring of the same patient who already registered in the tiral
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient Transfer Monitoring System
|
The subjects will be provided with portable oximeter and smart-phone which application for monitoring is installed, and the transmitted data will be monitored in real time via monitoring equipment in the (Patient-hospitalized) ward.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
frequency of risk factors which are detected during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
severity of risk factors which are detected during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
|
The severity is assessed as mild(risk factor was resolved without medical staff), moderate(resolved by medical staffs, but returned to the ward), and severe(not resolved by medical staffs, needs other method such as CPCR call, invasive intervention).
|
from the beginning to immediately after the end of the patient transfer
|
|
reason of decreased oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
duration of decreased oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
change from baseline in Oxygen saturation
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
the time from detecting risk factor to medical response
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
Death
Time Frame: from admission to discharge, up to 8 months
|
from admission to discharge, up to 8 months
|
|
|
admission to intensive care units
Time Frame: from admission to discharge, up to 8 months
|
from admission to discharge, up to 8 months
|
|
|
Adverse events related to the study
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
|
|
medical staffs who managed the alarmed event during transfer
Time Frame: from the beginning to immediately after the end of the patient transfer
|
from the beginning to immediately after the end of the patient transfer
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Chang-Min Choi, MD, Ph. D, Asan Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- C2018-00554
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.